SC
LLY icon

Sapient Capital’s Eli Lilly LLY Stock Holding History

Sapient Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.71B Buy
1,478,787
+31,247
+2% +$36.9M 23.01% 1
2026
Q2 		$1.74B Buy
1,447,540
+3,185
+0.2% +$3.25M 22.72% 1
2026
Q1 		$1.33B Sell
1,444,355
-54,261
-4% -$55M 20.02% 1
2025
Q4 		$1.62B Buy
1,498,616
+20,737
+1% +$19.8M 22.72% 1
2025
Q3 		$1.07B Buy
1,477,879
+259,392
+21% +$193M 16.53% 1
2025
Q2 		$950M Buy
1,218,487
+9,903
+0.8% +$7.7M 17.01% 1
2025
Q1 		$998M Buy
1,208,584
+25,936
+2% +$21.6M 19.69% 1
2024
Q4 		$913M Sell
1,182,648
-1,829
-0.2% -$1.51M 17.43% 1
2024
Q3 		$1.05B Buy
1,184,477
+247
+0% +$222K 21.07% 1
2024
Q2 		$1.07B Buy
1,184,230
+6,908
+0.6% +$5.53M 22.32% 1
2024
Q1 		$916M Buy
1,177,322
+7,111
+0.6% +$5.06M 20.29% 1
2023
Q4 		$682M Buy
+1,170,211
New +$683M 17.6% 1

Other funds holding LLY

PCA
Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
OMC
Overbrook Management Corp New York $643M AUM 29.06% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

Sapient Capital's LLY Position: Q3 2026 in Review

Sapient Capital increased its Eli Lilly (LLY) stake by 2.2% in Q3 2026, buying an estimated $36.9M and bringing the position to 1,478,787 shares worth $1.71B. The position accounts for 23.01% of the portfolio, ranked #1.

Sapient Capital first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.74B in Q2 2026. 162 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Sapient Capital held 1,478,787 shares of Eli Lilly worth $1.71B as of Q3 2026.
  • Sapient Capital bought 31,247 Eli Lilly shares in Q3 2026, an estimated $36.9M.
  • Eli Lilly made up 23.01% of Sapient Capital's portfolio in Q3 2026, its #1 holding.
  • Sapient Capital first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
  • Sapient Capital's Eli Lilly position peaked at $1.74B in Q2 2026.
  • 162 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Sapient Capital's 13F filing for Q3 2026, filed 8 Oct 2026.